For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Navitor Pharmaceuticals, Inc.

USPTO Granted Patents = 18

EPO Patents = 2

Forward Citations = 68

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Eddine Saiah (13 out of 33 patents)

David John O'Neill (9 out of 16 patents)

Sridhar Narayan (6 out of 12 patents)

4. Kristina Michelle Fetalvero (5 out of 5 patents)

5. Shomit Sengupta (5 out of 6 patents)

6. Silvia Lenzini (3 out of 3 patents)

7. Seong Woo Anthony Kang (3 out of 5 patents)

8. George Vlasuk (3 out of 3 patents)

9. Andrew Brearley (2 out of 2 patents)

10. Jonathan Bentley (2 out of 12 patents)

11. Steven D Targum (2 out of 2 patents)

12. Sarah Mahoney (1 out of 1 patent)

13. Lisa Molz (1 out of 1 patent)

14. Steven Leventer (1 out of 1 patent)

15. Steven Leventer (1 out of 1 patent)

18 patents: Sort by Forward Citations

1. 12465583 - Methods of treatment using an mTORC1 modulator (2025-11-11),

2. 12427130 - Modulators of Sestrin-GATOR2 interaction and uses thereof (2025-09-30),

3. 12378263 - Modulators of sestrin-GATOR2 interaction and uses thereof (2025-08-05),

4. 12252456 - Polymorphic compounds and uses thereof (2025-03-18),

5. 11723890 - Methods of treatment using an mTORC1 modulator (2023-08-15),

6. 11697633 - Polymorphic compounds and uses thereof (2023-07-11),

7. 11679090 - Modulators of Sestrin-GATOR2 interaction and uses thereof (2023-06-20),

8. 11345654 - Polymorphic compounds and uses thereof (2022-05-31),

9. 11339144 - Heteroaryl Rheb inhibitors and uses thereof (2022-05-24),

10. 11325924 - Modulators of Sestrin-GATOR2 interaction and uses thereof (2022-05-10),

11. 10980784 - Rapamycin analogs and uses thereof (2021-04-20),

12. 10912750 - Modulators of Sestrin-GATOR2 interaction and uses thereof (2021-02-09),

13. 10844013 - Phenyl amino piperidine mTORC inhibitors and uses thereof (2020-11-24),

14. 10752644 - Modulators of Sestrin-GATOR2 interaction and uses thereof (2020-08-25),

15. 10683308 - Rapamycin analogs and uses thereof (2020-06-16),

Navitor Pharmaceuticals, Inc. is a biotechnology company that develops novel therapeutics targeting the mTOR pathway for the treatment of various diseases. They specialize in the discovery and optimization of small molecules that modulate mTOR signaling to address unmet medical needs. Their innovative approach holds potential for treating cancer, autoimmune disorders, and metabolic diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

18 Patents

#127 in Cambridge, MA

#1,058 in Massachusetts

#17,421 in US

#33,199 in the World

Cambridge, MA, United States of America

Navitor Pharmaceuticals, Inc.

Forward Citations = 68

15 inventors:

Eddine Saiah (13 out of 33 patents)

David John O'Neill (9 out of 16 patents)

Sridhar Narayan (6 out of 12 patents)

4. Kristina Michelle Fetalvero (5 out of 5 patents)

5. Shomit Sengupta (5 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…